NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 230 filers reported holding NEKTAR THERAPEUTICS in Q3 2022. The put-call ratio across all filers is 0.14 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $7,269 | -68.9% | 10,341 | 0.0% | 0.00% | – |
| Q4 2022 | $23,371 | -29.2% | 10,341 | +1.7% | 0.00% | -100.0% |
| Q3 2022 | $33,000 | -91.1% | 10,171 | -50.7% | 0.00% | -85.7% |
| Q3 2021 | $371,000 | +1.4% | 20,644 | -3.2% | 0.01% | 0.0% |
| Q2 2021 | $366,000 | -4.7% | 21,324 | +11.0% | 0.01% | -12.5% |
| Q1 2021 | $384,000 | +20.0% | 19,203 | +2.1% | 0.01% | +14.3% |
| Q4 2020 | $320,000 | +2.6% | 18,807 | -0.1% | 0.01% | -12.5% |
| Q3 2020 | $312,000 | -16.1% | 18,833 | +17.2% | 0.01% | -20.0% |
| Q2 2020 | $372,000 | – | 16,067 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVEY CAPITAL MANAGEMENT INC | 598,400 | $10,083,000 | 3.98% |
| Opus Point Partners Management, LLC | 348,583 | $5,874,000 | 3.88% |
| Camber Capital Management LP | 3,500,000 | $58,975,000 | 3.81% |
| 1492 Capital Management LLC | 180,601 | $3,043,000 | 2.21% |
| Virtus ETF Advisers LLC | 38,260 | $645,000 | 1.77% |
| Cormorant Asset Management, LP | 765,156 | $12,893,000 | 1.54% |
| Rhenman & Partners Asset Management AB | 581,000 | $9,790,000 | 1.48% |
| Granahan Investment Management | 2,082,155 | $35,084,000 | 1.21% |
| BRIDGER MANAGEMENT, LLC | 1,563,862 | $26,351,000 | 0.87% |
| RICE HALL JAMES & ASSOCIATES, LLC | 899,531 | $15,157,000 | 0.87% |